Skip to content. | Skip to navigation

Personal tools

Sections

Tutelles

logo Inserm      logo cnrslogo ENSL       logo ucb1

 

logo ENSL       logo ucb1

 

 

 

You are here: Home / Teams / Durantel D - HepVir / What's new for us? / Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes

Insights on the antiviral mechanisms of action of the TLR1/2 agonist Pam3CSK4 in hepatitis B virus (HBV)-infected hepatocytes

Desmares et al., Antiviral Research, 2022 / Team HepVir
Filed under: